Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.48 |
| ▸ | ACACA | Q13085 | 2/20 | 0.48 |
| ▸ | EBP | Q15125 | 8/20 | 0.48 |
| ▸ | CDC25A | P30304 | 8/20 | 0.44 |
| ▸ | CDC25B | P30305 | 8/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL300737 | 1.00 | ACLY (0.48) | ACLYACACAEBPCDC25ACDC25B | |
| SCHEMBL29934951 | 0.87 | CDC25A (0.59) | ACLYACACAEBPCDC25ACDC25B | |
| SCHEMBL14116745 | 0.85 | CDC25A (0.51) | ACLYACACAEBPCDC25ACDC25B | |
| SCHEMBL3285801 | 0.84 | ACLY (0.61) | ACLYACACAEBPPTPN11HSD11B1 | |
| SCHEMBL3285804 | 0.84 | ACLY (0.61) | ACLYACACAEBPPTPN11HSD11B1 | |
| SCHEMBL2450676 | 0.82 | CDC25A (0.46) | ACLYACACAEBPCDC25ACDC25B | |
| SCHEMBL2450675 | 0.82 | CDC25A (0.46) | ACLYACACAEBPCDC25ACDC25B | |
| Cycloartanol SCHEMBL12152356 | 0.81 | ACLY (0.67) | ACLYACACAEBPCDC25ACDC25B | |
| Cycloartanol SCHEMBL1881616 | 0.81 | ACLY (0.67) | ACLYACACAEBPCDC25ACDC25B | |
| Cycloartanol SCHEMBL13801860 | 0.81 | ACLY (0.67) | ACLYACACAEBPCDC25ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59036623-A | — | — | None | — | — | JP | disclosed |
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S | 2011-01-27 | — | — | US | disclosed |
| US-7713942-B2 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2010-05-11 | — | — | US | disclosed |
| EP-2011517-A1 | Polynucleotide binding complexes comprising sterols and saponin | Nordic Vaccine Technology A/S (DK) | 2009-01-07 | — | — | EP | disclosed |
| EP-1377320-B1 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY AS (DK) | 2008-10-01 | — | — | EP | disclosed |
| US-20040185057-A1 | Therapeutical vaccination | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2004-09-23 | — | — | US | disclosed |
| EP-1409009-A1 | THERAPEUTICAL VACCINATION | Nordic Vaccine Technology A/S (DK) | 2004-04-21 | — | — | EP | disclosed |
| US-20030118635-A1 | Polynucleotide binding complexes comprising sterols and saponins | ISCONOVA AB (SE) | 2003-06-26 | — | — | US | disclosed |
| WO-2002102407-A1 | THERAPEUTICAL VACCINATION | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-12-27 | — | — | WO | disclosed |
| JP-S5936623-A | INDUCING AGENT FOR INTERFERON | ZENYAKU KOGYO KK | 1984-02-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | LSS, SNRPE, HLA-C | ACLY 694/4885ACACA 1098/4885EBP 500/4885 |
| US-20030118635-A1 | Polynucleotide binding complexes comprising sterols and saponins | SNRPE, SNRPF, HNRNPAB | ACLY 578/4885ACACA 922/4885EBP 494/4885 |
| US-20040185057-A1 | Therapeutical vaccination | ICOS, CD69, HAVCR2 | ACLY 1657/4885ACACA 2235/4885EBP 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.